Alopecia Clinical Trials

A listing of Alopecia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Phoenix Arizona 85018

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Tucson Arizona 85724

A clinical trial to evaluate treatments using 7% (w/v) Tempol alcohol-based gel (MTS-01) and alcohol-based gel for patients with Alopecia

Arkansas

Hot Springs Arkansas 71913

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Jonesboro Arkansas 72401

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Little Rock Arkansas 72205

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

California

UPDATED

Irvine California 92618

A clinical trial seeking patients for a research study for the treatment of Hair Disease

Oceanside California 92056

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Palo Alto California 94304

A clinical trial seeking patients for a research study for the treatment of Androgenic Alopecia

San Diego California 92123

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Santa Rosa California 95405

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Connecticut

Milford Connecticut 06460

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Florida

Deland Florida 32720

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Hialeah Florida 33012

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Jacksonville Florida 32207

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Miami Florida 33175

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

North Miami Florida 33161

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

View More ▼

UPDATED

Orange Park Florida 32073

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Orlando Florida 32806

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Tampa Florida 33613

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

UPDATED

Tampa Florida 33624

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Georgia

Atlanta Georgia 30342

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Idaho

Boise Idaho 83642

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Illinois

Champaign Illinois 61820

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Chicago Illinois 60611

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Kansas

Shawnee Mission Kansas 66218

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Michigan

Clinton Township Michigan 48038

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Minnesota

Fridley Minnesota 55432

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Minneapolis Minnesota 55455

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Montana

Billings Montana 59102

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

New York

Mount Sinai Medical Center
New York New York 10029

An Exploratory Study to Evaluate the Safety and Efficacy of Secukinumab in the Treatment of Extensive Alopecia Areata

Sadick Research Group
New York New York 10075

Study to Evaluate Safety and Efficacy of a Nutraceutical Supplement with Standardized Botanicals for Treatment of Hair Loss and Thinning in Females

View More ▼

Williamsville New York 14221

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

North Carolina

Cary North Carolina 27518

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Winston-Salem North Carolina 27157

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Ohio

Cleveland Ohio 44122

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Columbus Ohio 43213

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Tiffin Ohio 44883

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Oklahoma

UPDATED

Tulsa Oklahoma 74136-7028

Patients are needed to participate in a clinical research study of PF-06651600, PF-06700841 and Placebo to evaluate Alopecia Areata

Oregon

Portland Oregon 97210

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Pennsylvania

Bryn Mawr Pennsylvania 19010

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Hershey Pennsylvania 17033

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Philadelphia Pennsylvania 19104

A clinical trial to evaluate treatments using 7% (w/v) Tempol alcohol-based gel (MTS-01) and alcohol-based gel for patients with Alopecia

South Carolina

Greer South Carolina 29650

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

Myrtle Beach South Carolina 29572

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Texas

Research Across America, Plano
Plano Texas 75093

Hair Loss Study For Men & Women

View More ▼

Austin Texas 78759

A clinical trial to evaluate treatments using Bimatoprost for patients with Alopecia, Alopecia, Androgenetic or Baldness

Austin Texas 78749

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)

Austin Texas 78759

Patients are needed to participate in a clinical research study evaluating setipiprant, placebo and finasteride for the treatment of Alopecia

College Station Texas 77845

A clinical trial to evaluate treatments using Bimatoprost for patients with Alopecia, Alopecia, Androgenetic or Baldness

Utah

Salt Lake City Utah 84124

A clinical trial to evaluate treatments using MLE4901 40mg, MLE4901 60mg, MLE4901 80mg and Placebo for patients with Polycystic Ovary Syndrome (PCOS)